[go: up one dir, main page]

WO1997003567A1 - Solubilization of spent tea leaves - Google Patents

Solubilization of spent tea leaves Download PDF

Info

Publication number
WO1997003567A1
WO1997003567A1 PCT/DK1996/000262 DK9600262W WO9703567A1 WO 1997003567 A1 WO1997003567 A1 WO 1997003567A1 DK 9600262 W DK9600262 W DK 9600262W WO 9703567 A1 WO9703567 A1 WO 9703567A1
Authority
WO
WIPO (PCT)
Prior art keywords
glucanase
tea leaves
spent
treatment
spent tea
Prior art date
Application number
PCT/DK1996/000262
Other languages
French (fr)
Inventor
Yasukazu Kusayama
Original Assignee
Novo Nordisk A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk A/S filed Critical Novo Nordisk A/S
Priority to AU63531/96A priority Critical patent/AU6353196A/en
Publication of WO1997003567A1 publication Critical patent/WO1997003567A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01006Endo-1,3(4)-beta-glucanase (3.2.1.6)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00Tea; Tea substitutes; Preparations thereof
    • A23F3/16Tea extraction; Tea extracts; Treating tea extract; Making instant tea
    • A23F3/166Addition of, or treatment with, enzymes or microorganisms

Definitions

  • TECHNICAL FIELD This invention relates to a process for reducing the amount of spent tea leaves.
  • BACKGROUND ART Canned or bottled tea drinks as well as instant tea are produced in industrial scale by hot water extraction of tea leaves, and the producers face a problem in disposing of the spent tea leaves after the extraction.
  • the spent tea leaves are mostly treated as industrial waste, and the producers have to pay for this disposal, so there is a need for a process to reduce the amount of the spent tea leaves.
  • US-A-5 196 214 describes a process for the preparation of tea extracts from spent tea residues comprising hydrolysis with cellulase derived from the fungus Trichoderma reesei or T. viride, particularly Celluclast ® (product of Novo Nordisk A/S).
  • US-A-4 483 876 describes an enzymatic treatment of tea leaves before the hot water extraction.
  • the enzyme used is described as SPSase derived from Aspergillus aculeatus.
  • cellulase is not very effective in reducing the amount of spent tea leaves, and it is the object of this invention to provide a more effective process of reducing the amount of spent leaves.
  • the process of the invention is applicable to any kind of spent tea leaves from hot aqueous extraction.
  • Examples are spent leaves of Oolong tea, black tea and green tea, used in the production of canned or bottled tea drinks or instant tea.
  • the spent tea leaves may be treated directly in wet condition, or they may be dried and optionally ground before the treatment.
  • the process of the invention is particularly applicable in situations where it is desired to reduce the amount of wet leaves before disposal.
  • the separated liquid after the treatment may be used in the production of canned or bottled tea drinks or instant tea, thus increasing the yield, or it may be discarded.
  • ⁇ -glucanase The enzyme used in the process of the invention is a ⁇ -glucanase (EC
  • Many microbially produced enzyme preparation contain ⁇ -glucanase together with other carbohydrases such as arabanase, cellulase, xylanase and other hemi-cellulase activities.
  • Such mixed enzyme preparation can be used in the process of the invention.
  • Some preferred microbial ⁇ -glucanase preparations are derived from the following sources:
  • Aspergillus particularly A. niger (available as Finizym ® from Novo Nordisk) and A. aculeatus (available as Viscozyme ® from Novo Nordisk).
  • Humicola, particularly H. insolens available as UltrafloTM from Novo
  • Bacillus particularly B. subtilis (available as Cereflo ® from Novo Nordisk).
  • ⁇ -glucanase from Aspergillus aculeatus is particularly preferred as this enzyme is particularly effective.
  • Wet spent tea leaves typically contain 20-35 dry substance; water is conveniently added to obtain a suitable consistency before the addition of enzyme, and the enzyme treatment may be carried out by incubating the spent tea leaves at a dry substance content of 2-20% (particularly 5-10%) by weight.
  • the pH is preferably in the range of 3-6.5 (particularly 3.5-6) in the case of ⁇ -glucanase from Aspergillus, and in the range of 5-9 (particularly 6-8) in the case of ⁇ -glucanase from Bacillus and Humicola.
  • the spent tea leaves typically have a slightly acid pH, so advantageously, a treatment with ⁇ -glucanase from Aspergillus can be carried out without any pH adjustment.
  • the temperature is preferably in the range 10-70°C (particularly 30-60°C).
  • the incubation time may be from 0.5-24 hours. It may be convenient to incubate over-night (typically 12-24 hours), e.g. starting the incubation at 50-60°C and letting the temperature drop. Alternatively, it may be convenient to use a shorter incubation time (e.g. 1-5 hours) for processing within a working day.
  • a suitable dosage of ⁇ -glucanase for an incubation of about 4 hours may be in the range 0.1-50 (particularly 0.3-10) units/g of dry substance in the spent tea leaves. The dosage should be adjusted according to the incubation time and can be reduced to about one third to one fourth in the case of over-night incubation.
  • Stirring may be used during the incubation; or stirring may be used initially to mix the spent tea leaves, and after that the stirring may be discontinued.
  • the enzyme may be inactivated by heating, if needed.
  • the liquid may be separated from the mixture after the incubation by conventional means, e.g. filtration, centrifugation or pressing.
  • 1 ⁇ -glucanase unit is defined as the amount of enzyme which forms reducing sugar equivalent to 1 m-mole of glucose per minute, using 0.5% of ⁇ - glucan as substrate at 30.0°C. The measurement is made near the pH optimum of the ⁇ -glucanase in question. pH 5.0 is used for ⁇ -glucanase from Aspergillus, and pH 7.5 for ⁇ -glucanase from Bacillus and Humicola.
  • Spent green tea leaves were dehydrated for 10 minutes in a washer-dryer.
  • ⁇ -glucanase preparation derived from Aspergillus were used according to the invention, and a cellulase preparation was used to represent the prior art.
  • the enzymes tested and the results with each enzyme were as follows: Microbial origin Product name ⁇ -glucanase Weight loss activity (%) (units/g, pH 5)
  • Spent green tea leaves, black tea leaves and Oolong tea leaves were treated with Viscozyme, in water or buffer. Besides measuring the weight loss, the pH was also measured before and after the treatment. Other conditions were as in Example 1.
  • Example 2 The experiments of Example 2 with buffer were repeated with different enzyme dosages. The results are given as % weight loss for each kind of tea and each enzyme dosage:

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Tea And Coffee (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

An enzymatic treatment with a β-glucanase is surprisingly effective in reducing the amount of spent tea leaves, and accordingly the invention provides a process for reducing the amount of spent tea leaves, comprising treating the spent tea leaves with a β-glucanase, followed by separation of liquid.

Description

SOLUBILIZATION OF SPENT TEA LEAVES
TECHNICAL FIELD This invention relates to a process for reducing the amount of spent tea leaves.
BACKGROUND ART Canned or bottled tea drinks as well as instant tea are produced in industrial scale by hot water extraction of tea leaves, and the producers face a problem in disposing of the spent tea leaves after the extraction. The spent tea leaves are mostly treated as industrial waste, and the producers have to pay for this disposal, so there is a need for a process to reduce the amount of the spent tea leaves.
US-A-5 196 214 describes a process for the preparation of tea extracts from spent tea residues comprising hydrolysis with cellulase derived from the fungus Trichoderma reesei or T. viride, particularly Celluclast® (product of Novo Nordisk A/S). In contrast, US-A-4 483 876 describes an enzymatic treatment of tea leaves before the hot water extraction. The enzyme used is described as SPSase derived from Aspergillus aculeatus.
We have found that cellulase is not very effective in reducing the amount of spent tea leaves, and it is the object of this invention to provide a more effective process of reducing the amount of spent leaves.
DETAILED DESCRIPTION OF THE INVENTION Spent tea leaves The process of the invention is applicable to any kind of spent tea leaves from hot aqueous extraction. Examples are spent leaves of Oolong tea, black tea and green tea, used in the production of canned or bottled tea drinks or instant tea. The spent tea leaves may be treated directly in wet condition, or they may be dried and optionally ground before the treatment. The process of the invention is particularly applicable in situations where it is desired to reduce the amount of wet leaves before disposal. The separated liquid after the treatment may be used in the production of canned or bottled tea drinks or instant tea, thus increasing the yield, or it may be discarded.
β-glucanase The enzyme used in the process of the invention is a β-glucanase (EC
3.2.1.6), also called endo-1 ,3(4)-β- glucanase.
Many microbially produced enzyme preparation contain β-glucanase together with other carbohydrases such as arabanase, cellulase, xylanase and other hemi-cellulase activities. Such mixed enzyme preparation can be used in the process of the invention.
Some preferred microbial β-glucanase preparations are derived from the following sources:
Aspergillus, particularly A. niger (available as Finizym® from Novo Nordisk) and A. aculeatus (available as Viscozyme® from Novo Nordisk). Humicola, particularly H. insolens (available as Ultraflo™ from Novo
Nordisk).
Bacillus, particularly B. subtilis (available as Cereflo® from Novo Nordisk). β-glucanase from Aspergillus aculeatus (Viscozyme) is particularly preferred as this enzyme is particularly effective.
Process conditions
Wet spent tea leaves typically contain 20-35 dry substance; water is conveniently added to obtain a suitable consistency before the addition of enzyme, and the enzyme treatment may be carried out by incubating the spent tea leaves at a dry substance content of 2-20% (particularly 5-10%) by weight.
The pH is preferably in the range of 3-6.5 (particularly 3.5-6) in the case of β-glucanase from Aspergillus, and in the range of 5-9 (particularly 6-8) in the case of β-glucanase from Bacillus and Humicola. The spent tea leaves typically have a slightly acid pH, so advantageously, a treatment with β-glucanase from Aspergillus can be carried out without any pH adjustment.
The temperature is preferably in the range 10-70°C (particularly 30-60°C). The incubation time may be from 0.5-24 hours. It may be convenient to incubate over-night (typically 12-24 hours), e.g. starting the incubation at 50-60°C and letting the temperature drop. Alternatively, it may be convenient to use a shorter incubation time (e.g. 1-5 hours) for processing within a working day. A suitable dosage of β-glucanase for an incubation of about 4 hours may be in the range 0.1-50 (particularly 0.3-10) units/g of dry substance in the spent tea leaves. The dosage should be adjusted according to the incubation time and can be reduced to about one third to one fourth in the case of over-night incubation.
Stirring may be used during the incubation; or stirring may be used initially to mix the spent tea leaves, and after that the stirring may be discontinued.
After the incubation, the enzyme may be inactivated by heating, if needed.
The liquid may be separated from the mixture after the incubation by conventional means, e.g. filtration, centrifugation or pressing.
Enzyme activity units
1 β-glucanase unit is defined as the amount of enzyme which forms reducing sugar equivalent to 1 m-mole of glucose per minute, using 0.5% of β- glucan as substrate at 30.0°C. The measurement is made near the pH optimum of the β-glucanase in question. pH 5.0 is used for β-glucanase from Aspergillus, and pH 7.5 for β-glucanase from Bacillus and Humicola.
EXAMPLES
Example 1
Comparison of enzymes at acidic pH
Spent green tea leaves were dehydrated for 10 minutes in a washer-dryer.
60 g (wet weight) of leaves were incubated with various enzymes at an enzyme dosage of 0.5% relative to the wet leaves in 180 mL of 0.1 M acetate buffer (pH
4.5) for 3 hours at 50°C with shaking. The leaves were then dehydrated again in the same manner and weighed. The results are given as weight loss in %.
Two β-glucanase preparation derived from Aspergillus were used according to the invention, and a cellulase preparation was used to represent the prior art. The enzymes tested and the results with each enzyme were as follows: Microbial origin Product name β-glucanase Weight loss activity (%) (units/g, pH 5)
Invention A. aculeatus Viscozyme 100 38%
A. niger Finizym 500L 500 29%
Prior art T. reesei Celluclast 1.5L - 11 %
It is seen that the two β-glucanase preparations according to this invention are much more effective than the cellulase preparation used in the prior art.
Example 2
Treatment of green, black and Oolong tea leaves
Spent green tea leaves, black tea leaves and Oolong tea leaves were treated with Viscozyme, in water or buffer. Besides measuring the weight loss, the pH was also measured before and after the treatment. Other conditions were as in Example 1.
The results were as follows. Blank tests carried out in water without enzyme or buffer showed no weight loss.
Tea type Green Black Oolong
Buffer + - + - + - pH before 4.5 5.8 4.5 5.0 4.5 5.2 pH after 4.5 4.8 4.4 4.1 4.6 4.5
% loss 44 42 28 32 27 27
It is seen that a significant weight loss is achieved with each type of spent tea leaves. Essentially the same effect is achieved with or without buffer. Example 3
Effect of enzyme dosage
The experiments of Example 2 with buffer were repeated with different enzyme dosages. The results are given as % weight loss for each kind of tea and each enzyme dosage:
Dosage of Type of tea Viscozyme
Green Black Oolong
0.1 % 25 14 7
0.5% 37 27 23
1.0% 43 30 28
A significant effect is seen at each dosage at these conditions.
Example 4
Treatment at neutral pH
Spent green tea leaves were treated with Ultraflo and Cereflo in 0.1 M phosphate buffer (pH 7). Other conditions were as in Example 1. Two β-glucanase preparations with optimum near neutral pH were used according to the invention: The enzyme activities used and the results were as follows:
Microbial origin Product name β-glucanase activity Weight loss (%) (units/g, pH 7.5)
Humicola insolens Ultraflo 50 18%
Bacillus subtilis Cereflo 200 15%
A significant effect is seen with both enzymes.

Claims

1. A process for reducing the amount of spent tea leaves, comprising treating the spent tea leaves in water with a β-glucanase derived from Aspergillus, Humicola or Bacillus, followed by separation of liquid.
2. The process of claim 1 wherein the β-glucanase is derived from a strain of Aspergillus, preferably A. aculeatus or A. niger.
3. The process of the preceding claim wherein the treatment is done at a pH in the range 3-6.5, preferably 3.5-6.
4. The process of claim 1 wherein the β-glucanase is derived from a strain of Humicola, preferably H. insolens.
5. The process of claim 1 wherein the β-glucanase is derived from a strain of Bacillus, preferably β. subtilis.
6. The process of claim 4 or 5 wherein the treatment is done at a pH in the range 5-9, preferably 6-8.
7. The process of any preceding claim wherein the spent tea leaves are present at a dry substance content of 2-20% by weight, preferably 5-10%.
8. The process of any preceding claim wherein the treatment is conducted at a temperature in the range of 10-70°C, preferably 30-60°C.
9. The process of any preceding claim wherein the treatment is continued for a period of 0.5 to 24 hours.
10. The process of any preceding claim wherein the treatment is continued for 1-5 hours, and the β-glucanase is present in an amount of 0.1-50 units per g of dry substance, preferably 0.3-10 units/g.
11. The process of any preceding claim wherein the treatment is continued for 12-24 hours, and the β-glucanase is present in an amount of 0.025-17 units per g of dry substance, preferably 0.075-3.3 units/g.
PCT/DK1996/000262 1995-07-14 1996-06-18 Solubilization of spent tea leaves WO1997003567A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU63531/96A AU6353196A (en) 1995-07-14 1996-06-18 Solubilization of spent tea leaves

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK82995 1995-07-14
DK0829/95 1995-07-14

Publications (1)

Publication Number Publication Date
WO1997003567A1 true WO1997003567A1 (en) 1997-02-06

Family

ID=8098024

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK1996/000262 WO1997003567A1 (en) 1995-07-14 1996-06-18 Solubilization of spent tea leaves

Country Status (2)

Country Link
AU (1) AU6353196A (en)
WO (1) WO1997003567A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020074589A (en) * 2001-03-20 2002-10-04 남 국 김 Digital uroflowmeter program by measuring the weight of collected urine

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135222A1 (en) * 1983-08-12 1985-03-27 THE PROCTER & GAMBLE COMPANY Enzymatic treatment of black tea leaf

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135222A1 (en) * 1983-08-12 1985-03-27 THE PROCTER & GAMBLE COMPANY Enzymatic treatment of black tea leaf

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020074589A (en) * 2001-03-20 2002-10-04 남 국 김 Digital uroflowmeter program by measuring the weight of collected urine

Also Published As

Publication number Publication date
AU6353196A (en) 1997-02-18

Similar Documents

Publication Publication Date Title
FI61718C (en) FOERFARANDE FOER FRAMSTAELLNING AV XYLOS GENOM ENZYMATISK HYDROLYS AV XYLANER
Biswas et al. Production, purification, and characterization of xylanase from a hyperxylanolytic mutant of Aspergillus ochraceus
Johnston et al. Use of proteases to reduce steep time and SO2 requirements in a corn wet‐milling process
US5952023A (en) Enzyme extraction process for tea
EP0460402B1 (en) Water soluble tea extracts
CA2184591A1 (en) Processing plant material with xylanase
US5925389A (en) Extraction process of tea with enzymes
US5919500A (en) Enzyme extraction process for tea
TWI552679B (en) Process for the production of extract of teas
JP2006014615A (en) Tea beverage and method for producing the same
JP4740186B2 (en) Method for producing high flavor tea extract with excellent umami
JP5396548B2 (en) Production method of tea extracts
CN102984949B (en) Process for producing tea extract
WO1997003567A1 (en) Solubilization of spent tea leaves
CA1299129C (en) Process for the filtration of thickened gluten
Okada Cellulase of Aspergillus niger
JP5400970B2 (en) Tea extract
JP5396546B2 (en) Production method of tea extracts
JP5406379B2 (en) Tea extract
Krishnamurthy et al. Purification and characterization of endo-1, 4-β-xylanase from Paecilomyces varioti Bainier
WO1995029598A1 (en) Enzymatic treatment of soy
CN103931873B (en) The preparation method of phenol cottonseed cake protein powder falls in a kind of ultraviolet
WO2012046348A1 (en) Tea extract
Bonhomme Endo-1, 4-. BETA.-glucanase and endo-1, 4-. BETA.-xylanase of the ciliate epidinium ecaudatum free of cellulolytic and hemicellulolytic bacteria.
JP2022007665A (en) Softening accelerant of beans

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase